
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1027 | 928 | 1027 | 882 | 1225 | 1906 |
Fund Return | 2.73% | -7.17% | 2.73% | -4.11% | 4.15% | 6.66% |
Place in category | 601 | 678 | 601 | 484 | 113 | 30 |
% in Category | 90 | 93 | 90 | 85 | 25 | 10 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
B Multistock Swiss Stock Fund CHF B | 111.78M | 2.73 | -4.11 | 6.66 | ||
B Multistock Swiss Stock Fund CHF C | 15.34M | 3.51 | -3.39 | 7.46 | ||
Multiflex S Carnot Efficient Energc | 91M | 4.86 | 0.81 | 3.40 | ||
Popso Suisse Investment Fund S Glob | 90.12M | 2.76 | 0.94 | 1.50 | ||
S CEAMS Quality Switzerland Equityb | 54.82M | 4.09 | -6.57 | 4.90 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.51B | 12.09 | 5.90 | 7.10 | ||
Pictet CH Institutional Swiss EquiI | 2.09B | 10.19 | 3.38 | 7.31 | ||
Pictet CH Institutional Swiss EquZD | 2.09B | 10.28 | 3.87 | 7.82 | ||
Pictet CH Institutional Swiss EquiP | 2.09B | 10.16 | 3.18 | 7.09 | ||
Pictet CH Institutional Swiss EquiZ | 2.09B | 8.90 | 2.54 | 8.57 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 8.62 | 92.03 | -5.42% | |
Roche Holding Participation | CH0012032048 | 6.08 | 261.80 | -6.00% | |
Nestle | CH0038863350 | 5.33 | 87.36 | -3.64% | |
ABB | CH0012221716 | 5.20 | 41.05 | -4.27% | |
Holcim | CH0012214059 | 4.99 | 85.66 | -5.54% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Sell | BUY |
Summary | Strong Sell | Sell | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review